Terms: = Bone cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1 AND Diagnosis
7 results:
1. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Kemps PG; Zondag TCE; Arnardóttir HB; Solleveld-Westerink N; Borst J; Steenwijk EC; van Egmond D; Swennenhuis JF; Stelloo E; Trambusti I; Verdijk RM; van Noesel CJM; Cleven AHG; Scheijde-Vermeulen MA; Koudijs MJ; Krsková L; Hawkins C; Egeler RM; Brok J; von Bahr Greenwood T; Svojgr K; Beishuizen A; van Laar JAM; Pötschger U; Hutter C; Sieni E; Minkov M; Abla O; van Wezel T; van den Bos C; van Halteren AGS
Blood Adv; 2023 Feb; 7(4):664-679. PubMed ID: 36083130
[TBL] [Abstract] [Full Text] [Related]
2. Chondroblastoma-like tumor of the skull in a patient with cardio-facio-cutaneous syndrome.
Fasciano D; Wei S; Li R; Siegal GP
Pathol Res Pract; 2018 Sep; 214(9):1510-1513. PubMed ID: 30100356
[TBL] [Abstract] [Full Text] [Related]
3. CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors.
Xerri L; Adélaïde J; Popovici C; Garnier S; Guille A; Mescam-Mancini L; Laurent C; Brousset P; Coze C; Michel G; Chaffanet M; Bouabdallah R; Coso D; Bertucci F; Birnbaum D
Am J Surg Pathol; 2018 Feb; 42(2):150-159. PubMed ID: 29194093
[TBL] [Abstract] [Full Text] [Related]
4. High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.
Papo M; Diamond EL; Cohen-Aubart F; Emile JF; Roos-Weil D; Gupta N; Durham BH; Ozkaya N; Dogan A; Ulaner GA; Rampal R; Kahn JE; Sené T; Charlotte F; Hervier B; Besnard C; Bernard OA; Settegrana C; Droin N; Hélias-Rodzewicz Z; Amoura Z; Abdel-Wahab O; Haroche J
Blood; 2017 Aug; 130(8):1007-1013. PubMed ID: 28679734
[TBL] [Abstract] [Full Text] [Related]
5. Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.
Lee LH; Gasilina A; Roychoudhury J; Clark J; McCormack FX; Pressey J; Grimley MS; Lorsbach R; Ali S; Bailey M; Stephens P; Ross JS; Miller VA; Nassar NN; Kumar AR
JCI Insight; 2017 Feb; 2(3):e89473. PubMed ID: 28194436
[TBL] [Abstract] [Full Text] [Related]
6. Phosphoflow-Based Evaluation of Mek Inhibitors as Small-Molecule Therapeutics for B-Cell Precursor Acute Lymphoblastic Leukemia.
George AA; Paz H; Fei F; Kirzner J; Kim YM; Heisterkamp N; Abdel-Azim H
PLoS One; 2015; 10(9):e0137917. PubMed ID: 26360058
[TBL] [Abstract] [Full Text] [Related]
7. Langerhans cell histiocytosis.
Grana N
Cancer Control; 2014 Oct; 21(4):328-34. PubMed ID: 25310214
[TBL] [Abstract] [Full Text] [Related]
